The three phases are activation in weeks 14, remodeling in weeks 58, and maintenance in weeks 912
Antioxidant vitamins and magnesium and the risk of hearing loss in the US general population
And the metabolic endpoint being measured
Anti-inflammatory drugs (eg, corticosteroids and non-steroidal anti-inflammatory drugs [NSAIDs]) Anti-malarial drugs (eg, chloroquine and hydroxychloroquine) Immune system modulators (eg, azathioprine and cyclophosphamide) Monoclonal antibodies (eg, belimumab and rituximab) What are Emerging Therapies for Lupus
Images were taken using Zeiss LSM 780 Laser Scanning and Zeiss Axiophot fluorescent microscopes
FDA Adverse Event Reporting System (FAERS) data may include reports of musculoskeletal symptoms in patients using GLP-1 receptor agonists, though these reports do not establish causation and may reflect coincidental timing rather than a true drug effect